QUERZOLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 10.717
AS - Asia 5.499
EU - Europa 4.021
SA - Sud America 897
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 135
OC - Oceania 19
Totale 21.437
Nazione #
US - Stati Uniti d'America 10.408
SG - Singapore 2.088
CN - Cina 1.445
IT - Italia 1.267
BR - Brasile 702
DE - Germania 620
VN - Vietnam 570
UA - Ucraina 473
GB - Regno Unito 366
HK - Hong Kong 364
TR - Turchia 316
FI - Finlandia 249
PL - Polonia 217
SE - Svezia 197
FR - Francia 186
BD - Bangladesh 176
CA - Canada 170
RU - Federazione Russa 136
IN - India 125
JP - Giappone 120
MX - Messico 99
ID - Indonesia 78
NL - Olanda 68
BE - Belgio 61
AR - Argentina 56
ZA - Sudafrica 55
ES - Italia 39
EC - Ecuador 36
IQ - Iraq 33
CO - Colombia 31
PK - Pakistan 29
AT - Austria 26
CZ - Repubblica Ceca 24
VE - Venezuela 24
MA - Marocco 23
LT - Lituania 22
UZ - Uzbekistan 20
MY - Malesia 16
PH - Filippine 16
AU - Australia 15
CL - Cile 14
AE - Emirati Arabi Uniti 12
CR - Costa Rica 12
PY - Paraguay 12
RO - Romania 12
EG - Egitto 11
KE - Kenya 11
SA - Arabia Saudita 11
JM - Giamaica 9
TN - Tunisia 9
UY - Uruguay 9
CH - Svizzera 8
AZ - Azerbaigian 7
BO - Bolivia 7
IR - Iran 7
JO - Giordania 7
KR - Corea 7
KZ - Kazakistan 7
NP - Nepal 7
AL - Albania 5
AO - Angola 5
DZ - Algeria 5
IE - Irlanda 5
OM - Oman 5
TT - Trinidad e Tobago 5
EU - Europa 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
MD - Moldavia 4
PE - Perù 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
LY - Libia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
DO - Repubblica Dominicana 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
PS - Palestinian Territory 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
Totale 21.265
Città #
Singapore 1.309
Ashburn 1.189
San Jose 803
Woodbridge 795
Chandler 612
Fairfield 593
Ann Arbor 548
Jacksonville 503
Santa Clara 486
Beijing 432
Houston 403
Hong Kong 360
New York 274
Wilmington 269
Seattle 253
Los Angeles 210
Warsaw 207
Izmir 198
Dallas 196
Cambridge 193
Ho Chi Minh City 175
Munich 171
Council Bluffs 167
Nanjing 160
Hanoi 140
Milan 116
Tokyo 116
Princeton 113
Buffalo 101
Shanghai 92
Ferrara 91
Lauterbourg 91
Helsinki 83
Boardman 80
Nanchang 72
Turku 72
São Paulo 71
Bremen 69
Brooklyn 65
Mexico City 65
Orem 65
Dearborn 61
Brussels 60
San Diego 60
Rome 57
Toronto 56
Montreal 55
Jakarta 53
Tianjin 49
Chennai 46
Shenyang 45
Hebei 41
Chicago 39
Atlanta 38
Denver 38
London 38
Changsha 37
Falls Church 36
Johannesburg 34
Bologna 33
Stockholm 32
Hefei 31
Manchester 31
Frankfurt am Main 29
Haiphong 29
The Dalles 29
Da Nang 28
Falkenstein 28
Phoenix 26
Poplar 26
Rio de Janeiro 25
Boston 24
Redwood City 24
San Mateo 24
Zhengzhou 24
Jiaxing 23
Jinan 23
San Francisco 22
Auburn Hills 21
Guangzhou 21
Moscow 21
Amsterdam 20
Charlotte 19
Philadelphia 19
Tashkent 18
Belo Horizonte 17
Norwalk 17
Nuremberg 17
Vienna 17
Brasília 16
New Delhi 16
Naples 15
Querétaro 15
Washington 15
Ankara 14
City of London 14
Guayaquil 14
Mountain View 14
Addison 13
Brno 13
Totale 13.728
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 666
Integrazione del Nottingham Prognostic Index con i fenotipi biologici per una migliore definizione prognostica delle pazienti affette da carcinoma della mammella. 570
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 305
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 304
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 283
Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases 270
Breast Cancer and Simian Virus 40 Infection 266
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 266
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 263
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 244
CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer 239
Valutazione biologica multiparametrica di 5284 carcinomi mammari infiltranti (1990-2005): il ruolo del patologo nelle scelte terapeutiche 237
Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation 237
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 236
Valutazione dell'espressione di GATA3 con tecnica del tissue microarray (TMA) e significato prognostico nel carcinoma mammario infiltrante 231
Application of quantitative analysis to biologic profile evaluation in breast cancer 230
miR-501 overexpression in renal carcinomas 229
CD8 + ve cell infiltration correlates with angiogenesis in non-small cell lung cancer (NSCLC) of patients with chronic obstructive pulmonary disease 228
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 228
Serologic investigation on undifferentiated nasopharyngeal carcinoma and Simian Virus 40 infection 227
Clinical-diagnostic meaning of mammary uptake accidentally detected during 18F-FDG PET/CT (PET): comparison between radiological imaging and histopathology. 225
Sentinel node study in early breast cancer 225
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 220
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 220
Espressione dell'oncoproteina virale antigene T-grande di SV40 in carcinomi mammari infiltranti valutata su Tissue micro arrays (TMAs) 220
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 219
Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer 215
Commentary on human mammary neoplasia. The Estrogen Receptor-promotion hypothesis 212
Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-insitutional study in Italy 212
Core needle biopsy in invasive breast cancer prognostic/predictive power: concordance with surgical speciemen and impact of immunophenotypes 211
Factors responsible of scintigraphic false-negative sentinel lymph node detection in brest cancer 210
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 208
Espressione dei MicroRNA nei carcinomi mammari 203
Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer 202
Tumour-infiltrating CD8+ cells expressing IL-10, but not CD8+, CD4+ and CD68+ cells, are associated with a better prognosis in patients with NSCLC 202
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer 202
An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer 200
The 70 Gene Mammaprint signature: Ferrara's experience 196
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 195
Quantitative immunoprofiles of breast cancer performed by image analysis 194
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 192
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 191
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 191
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 190
An original approach in the diagnosis of early breast cancer: use of the same radipharmaceutical for both non palpable lesions and sentinel node localization 189
Expression of IL-10 by CD8+ T Cells Is a Favorable Prognostic Factor in Non-Small Cell Lung Cancer 189
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 188
Biology and prognosis of 1685 recently diagnosed HER2 positive breast carcinomas 186
Axillary lymph node nanometastases are prognostic factors for metastatic relapse 186
A case of invasive solid papillary breast carcinoma resembling tall cell variant of papillary thyroid carcinoma 185
Prognostic and predictive factors related to metastatic breast cancer clinical history: an outcome study [Fattori prognostici e predittivi nella storia clinica del carcinoma metastatico della mammella: Uno studio di esito] 184
Loss of methylation at chromosome 11p15.5 is common in human adult tumors 183
Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies 183
Biological tissue characterisation in narrow beam x-ray scattering techniques 181
The 70 gene Mammaprint signature: a comparison with traditional clinico-pathological parameters. 179
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 178
Role of the miR-501 in Renal Carcinomas 177
Oncogenic role of miR-483-3p at the IGF2/483 locus 174
Increased neurokinin-2 receptor expression in alveolar macrophages of smokers with COPD 173
Prevalence of post-stress myocardial stunning by gated-SPECT in diabetic patients: results of a prospective, multi-center trial 172
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 171
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: Evidence from a retrospective study 170
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 169
Immunocytochemical Demonstration of Estrogen Receptors by Monoclonal antibodies in Human breast cancer: Correlation with estrogen receptor assay by Dextran-coated Charcoal Method 169
Comparison of cytology test in patients under surveillance after transurethral resection of superficial urothelial carcinoma 169
Interleukin (IL)-10 expression in non-small cell lung cancer is associated with cigarette smoking 168
The 70 gene Mammaprint Signature: a comparison with traditional clinco-pathological tools. 166
Expression of p21 ras gene products in breast cancer relates to histological types and to receptor nodal status 166
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 165
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 164
Increased of A3 adenosine receptors by depleted expression of polycystic kidney disease-1 gene (PKD1) in human renal cell and tissues: implication for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells 163
Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer 163
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 162
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 159
Interobserver reproducibility of immunohistochemical HER-2/neu assessment in human breast cancer: An update from INQAT round III 159
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features 159
Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma) 158
Biological staging of incipient, in situ and invasive breast carcinomas 157
Tumor infiltrating lymphocytes in triple negative breast cancer and correlations with prognosis 157
Quality control for biomarker determination in oncology: The experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT) 156
Urovysion(TM) test: confronto tra citologia convenzionale e citologia molecolare nel follow-up di pazienti affetti da patologia neoplastica dell'urotelio 153
Observational DEMETRA STUDY: survival of metastatic breast carcinoma patients after treatment with Trastuzumab 152
Sentinel node and bone marrow micro metastases and nanometastases 146
Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision 144
Lymph node micrometastases do influence breast cancer outcome 141
Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. 139
Interobserver reproducibility of immunohistochemical HER-2/neu evaluation in human breast cancer: The real-world experience 134
Pattern of distant recurrence according to the molecular subtypes identified by immunohistochemistry in women with early breast cancer 129
MicroRNAs: toward the clinic for breast cancer patients 127
The 70-Gene Mammaprint Signature for risk stratification in breast cancer: a comparison with traditional pathological and clinical tools 126
Assessment of Proliferative rate of breast cancer by Ki-67 Monoclonal Antibody 126
Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters 123
MicroRNA gene expression deregulation in human breast cancer 121
Tumor infiltrating lymphocyte (TIL) and CD8+ cells in TNBC: new prognostic markers 115
Macrophage expression of IL-10 is a prognostic factor in non-small cell lung cancer. 115
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): Interim results 114
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 113
I Tissue micro arrays come strumento di ricerca e loro possibile utilizzo nella pratica clinica routinaria 111
null 111
Fattori predittivi del rischio di ulteriore metastatizzazione linfonodale ascellare in pazienti con linfonodo sentinella micrometastatico da tumore della mammella in fase precoce 109
Totale 19.440
Categoria #
all - tutte 88.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 673
Totale 89.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.235 0 118 70 87 95 52 66 87 52 104 101 403
2022/20231.372 98 113 55 184 263 213 63 126 142 7 67 41
2023/2024729 68 63 45 21 56 167 30 53 8 17 30 171
2024/20253.026 91 84 225 84 376 282 83 154 513 316 448 370
2025/20268.205 814 306 697 1.046 1.258 552 920 383 822 837 370 200
2026/2027410 217 193 0 0 0 0 0 0 0 0 0 0
Totale 21.437